ArticleiScience2026

Single- and dual-target CAR-T cells targeting HBsAg and GPC3 to balance safety and antitumor efficacy in HBV-positive hepatocellular carcinoma.

Quangang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.